Biochemical study of idebenone effect on mitochondrial metabolism of yeast

Cell Biology International

Volumn 32, Issue 1, 2008, Pages 146-150

  Chapela, Sebastián P ^a   Burgos, Hilda I ^a   Salazar, Ana I ^a   Nievas, Inés ^a   Kriguer, Norberto ^a   Stella, Carlos A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Idebenone; Mitochondrial potential; Saccharomyces cerevisiae

Indexed keywords

CARBON; IDEBENONE; OXYGEN; RHO FACTOR; RHODAMINE 123;

ARTICLE; CARBON SOURCE; CELL METABOLISM; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; DRUG EFFECT; DRUG INHIBITION; FLUORESCENCE; FUNGAL STRAIN; FUNGUS GROWTH; HYPOXIA; MAMMAL CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MODEL; NONHUMAN; OXYGEN SUPPLY; SACCHAROMYCES CEREVISIAE; YEAST;

CULTURE MEDIA; MITOCHONDRIA; OXYGEN; RHODAMINE 123; SACCHAROMYCES CEREVISIAE; UBIQUINONE;

MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 39149139976     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.08.003     Document Type: Article

References (29)

1. Ausubel F.M., Brent R., Kington R.E., Moore D.D., Seidma J.G., Smith J.A., et al. In: Ausubel F.M., Brent R., Kington R.E., Moore D.D., Seidma J.G., Smith J.A., and Struhl K. (Eds). Short protocols in molecular biology (1999), John Wiley and Sons, Inc.
2. Berger A.C., Vanderford T.H., Gernert K.M., Nichols J.W., Faundez V., and Corbett A.H. Saccharomyces cerevisiae Npc2p is a functionally conserved homologue of the human Niemann-Pick disease type C 2 protein, hNPC2. Eukaryot Cell 4 (2005) 1851-1862
3. Bunn H.F., and Poyton R.O. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76 (1996) 839-885
4. Calvo S., Jain M., Xie X., Sheth S.A., Chang B., Goldberger O.A., et al. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38 (2006) 576-582
5. Difco Laboratories. Difco manual of dehydrated culture media and reagents for microbiological and clinical laboratory procedures. Detroit 1, Michigan, 1953.
6. Esposito M., Ngo A., Ghelli A., Benelli B., Carelli V., McLennan H., et al. The interaction of Q analogs, particularly hydroxydecyl benzoquinine (idebenone), with the respiratory complexes of heart mitochondria. Arch Biochem Biophys 330 (1996) 395-400
7. Fetchko M., Auerbach D., and Stagljar I. Yeast genetic methods for the detection of membrane protein interactions: potential use in drug discovery. BioDrugs 17 (2003) 413-424
8. Galaris D., Barbouti A., and Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: the role of antioxidants and iron chelating compounds. Curr Pharm Des 12 (2006) 2875-2890
9. Geesaman B.J. Genetics of aging: implications for drug discovery and development. Am J Clin Nutr 83 (2006) 466S-469S
10. Genova M.L., Pich M.M., Biondi A., Bernacchia A., Falasca A., Bovina C., et al. Mitochondrial production of oxygen radical species and the role of coenzyme Q as an antioxidant. Exp Biol Med 228 (2003) 506-513
11. Geromel V., Darin N., Chretien D., Benit P., DeLonlay P., Rotig A., et al. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Genet Metab 77 (2002) 21-30
12. Gutzmann H., and Hadler D. Sustained efficacy and safety of idebenone in the treatment of alzheimer's disease: update on a 2-year double-blind multicentre study. J Neural Transm Suppl 54 (1998) 301-310
13. Kotliar N., Stella C.A., and Ramos E.H. Efecto de iones amonio sobre la entrada de l-leucina en S. cerevisiae. Represión e inhibición de los sistemas transportadores. Rev Arg Microbiol 22 (1990) 7-16
14. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 7 (2003) 35-51
15. Lavie L., Vishnevsky A., and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27 (2004) 123-128
16. Ma Y., Wang G.D., Wu L.W., and Hu R.D. Dynamical changing patterns of histological structure and ultrastructure of liver graft undergoing warm ischemia injury from non-heart-beating donor in rats. World J Gastroenterol 12 (2006) 4902-4905
17. Oechmichen M., and Meissner C. Cerebral hypoxia and ischemia: the forensic point of view: a review. J Forensic Sci 51 (2006) 880-887
18. Oliver S.G. Functional genomics: lessons from yeast. Philos Trans R Soc Lond B. Biol Sci 357 (2002) 17-23
19. Pannunzio V.G., Burgos H.I., Alonso M., Mattoon J.R., Ramos E.H., and Stella C.A. A simple chemical method for rendering wild type yeast permeable to Brefeldin A that does not require the presence of an erg6 mutation. J Biomed Biotechnol 3 (2004) 150-155
20. Paolino D., Iannone M., Cardile V., Renis M., Puglisi G., Rotiroti D., et al. Tolerability and improved protective action of idebenone-loaded pegylated liposomes on ethanol-induced injury in primary cortical astrocytes. J Pharm Sci 93 (2004) 1815-1827
21. Sakiko I., Ayumi O., and Kumiko N. Idebenone acts against growth of Helicobacter pylori by inhibiting its respiration. Antimicrob Agents Chemother 50 (2006) 2237-2239
22. Schols L., Meyer C., Schmid G., Wilhelms I., and Przuntek H. Therapeutic strategies in Friedreich's ataxia. J Neural Transm Suppl 68 (2004) 135-145
23. Seznec H., Simon D., Monassier L., Criqui-Filipe P., Gansmuller A., Rustin P., et al. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum Mol Genet 13 (2004) 1017-1024
24. Steinmetz L.M., Scharfe C., Deutschbauer A.M., Mokranjac D., Herman Z.S., Jones T., et al. Systematic screen for human disease genes in yeast. Nat Genet 31 (2002) 400-404
25. Stella C.A., Burgos H.I., Salellas M., Cristaldo M.L., Ramos E.H., and Kriguer N. l-Carnitine effect upon iron growth inhibition on Saccharomyces cerevisiae. Lett Drug Discov Develop 2 (2005) 184-193
26. Thal L.J., Grundman M., Berg J., Ernstrom K., Margolin R., Pfeiffer E., et al. Idebenone treatment fails to slow cognitive decline in alzheimer's disease. Neurology 61 (2003) 1498-1502
27. Vacher C., Garcia-Oroz L., and Rubinsztein D.C. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum Mol Genet 14 (2005) 3425-3433
28. Vavra J.J., and Johnson M.J. Aerobic and anaerobic biosynthesis of amino acids by bakers' yeast. J Biol Chem 220 (1956) 33-43
29. Walberg M.W. Applicability of yeast genetics to neurologic disease. Arch Neurol 57 (2000) 1129-1134